Physician profile
Bryan Hnatio
NPI 1992202790
$1,501.46
in general payments reported to CMS, 2019-2025
17 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $442 · 2023: $445 · 2024: $55.01 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $451.95 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $148.57 | 2025 | Rexulti |
| Lilly USA, LLC | $140.07 | 2021-2023 | Mounjaro, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $124.74 | 2025 | |
| Glaxosmithkline, LLC. | $124.58 | 2022-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $122.83 | 2021-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $114.98 | 2022-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.18 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $31.63 | 2021 | |
| Exact Sciences Corporation | $26.03 | 2025 | The Cologuard Plus Collection Kit |
| Esperion Therapeutics, INC. | $23.55 | 2025 | Nexletol |
| Lundbeck LLC | $22.59 | 2023 | Rexulti |
| Abbott Laboratories | $19.42 | 2022 | |
| Amgen INC. | $18.80 | 2023 | Otezla, Repatha |
| Pfizer INC. | $17.33 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Hnatio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.